Imperial College London
Portrait Picture

DrMatthewHarris

Faculty of Medicine, School of Public Health

Clinical Senior Lecturer in Public Health
 
 
 
//

Contact

 

+44 (0)20 7594 7452m.harris

 
 
//

Location

 

Reynolds BuildingCharing Cross Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Banstola:2023:10.1136/bmjopen-2022-069270,
author = {Banstola, A and Pokhrel, S and Hayhoe, B and Nicholls, D and Harris, M and Anokye, N},
doi = {10.1136/bmjopen-2022-069270},
journal = {BMJ Open},
pages = {1--10},
title = {Economic evaluations of interventional opportunities for the management of mental–physical multimorbidity: a systematic review},
url = {http://dx.doi.org/10.1136/bmjopen-2022-069270},
volume = {13},
year = {2023}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Objectives Economic evaluations of interventions for people with mental–physical multimorbidity, including a depressive disorder, are sparse. This study examines whether such interventions in adults are cost-effective.Design A systematic review.Data sources MEDLINE, CINAHL Plus, PsycINFO, Cochrane CENTRAL, Scopus, Web of Science and NHS EED databases were searched until 5 March 2022.Eligibility criteria We included studies involving people aged ≥18 with two or more chronic conditions (one being a depressive disorder). Economic evaluation studies that compared costs and outcomes of interventions were included, and those that assessed only costs or effects were excluded.Data extraction and synthesis Two authors independently assessed risk of bias in included studies using recommended checklists. A narrative analysis of the characteristics and results by type of intervention and levels of healthcare provision was conducted.Results A total of 19 studies, all undertaken in high-income countries, met inclusion criteria. Four intervention types were reported: collaborative care, self-management, telephone-based and antidepressant treatment. Most (14 of 19) interventions were implemented at the organisational level and were potentially cost-effective, particularly, the collaborative care for people with depressive disorder and diabetes, comorbid major depression and cancer and depression and multiple long-term conditions. Cost-effectiveness ranged from £206 per quality-adjusted life year (QALY) for collaborative care programmes for older adults with diabetes and depression at primary care clinics (USA) to £79 723 per QALY for combining collaborative care with improved opportunistic screening for adults with depressive disorder and diabetes (England). Conclusions on cost-effectiveness were constrained by methodological aspects of the included studies: choice of perspectives, time horizon and costing methods.Conclusions Economic evaluations of inte
AU  - Banstola,A
AU  - Pokhrel,S
AU  - Hayhoe,B
AU  - Nicholls,D
AU  - Harris,M
AU  - Anokye,N
DO  - 10.1136/bmjopen-2022-069270
EP  - 10
PY  - 2023///
SN  - 2044-6055
SP  - 1
TI  - Economic evaluations of interventional opportunities for the management of mental–physical multimorbidity: a systematic review
T2  - BMJ Open
UR  - http://dx.doi.org/10.1136/bmjopen-2022-069270
UR  - https://bmjopen.bmj.com/content/13/2/e069270
UR  - http://hdl.handle.net/10044/1/102901
VL  - 13
ER  -
Download